Added to YB: 2022-12-02
Pitch date: 2022-12-02
XFOR [bearish]
X4 Pharmaceuticals, Inc.
+90.17%
current return
Author Info
No bio for this author
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
X4 Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the research, development, and commercialization of novel therapeutics for the treatment of rare diseases of the immune system.
Market Cap
$399.0M
Pitch Price
$41.10
Price Target
N/A
Dividend
N/A
EV/EBITDA
-2.77
P/E
-3.06
EV/Sales
26.90
Sector
Biotechnology
Category
N/A
Show full summary:
X4 PHARMACEUTICALS INC XFOR
A summary for this pitch has not been created yet.
Read full article (0 min)